Skip to main content
. 2017 Apr 26;10:2305–2313. doi: 10.2147/OTT.S135013

Figure 1.

Figure 1

Treatment schedule of APL patients classified as low- to intermediate-risk category.

Abbreviations: 6-MP, 6-mercaptopurine; APL, acute promyelocytic leukemia; As2O3, arsenic trioxide; ATRA, all-trans retinoic acid; CR, complete remission; IDA, idarubicin; IV, intravenous; Mitox, mitoxantrone; MTX, methotrexate; PO, per oral.